CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® Elite

By AbbVie for Prnewswire
January 26, 2021 Original Article >

NEW TECHNOLOGY ALLOWS FOR THE TREATMENT OF TWO AREAS OF FAT AT ONCE AND NEW ELITE APPLICATORS DESIGNED FOR IMPROVED FIT AND COMFORT

IRVINE, Calif., Jan. 26, 2021 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of CoolSculpting® Elite, its next generation fat reduction system with applicators designed to complement the body’s natural curves. CoolSculpting® Elite harnesses proven CoolSculpting® technology to target, freeze, and eliminate treated fat cells. CoolSculpting® Elite is FDA cleared to treat visible fat bulges in nine areas of the body including the thigh, abdomen, and flank, along with bra fat, back fat, underneath the buttocks (also known as banana roll), upper arm, and the submental and submandibular areas.

CoolSculpting® Elite Logo (PRNewsfoto/AbbVie)
CoolSculpting® Elite System (PRNewsfoto/AbbVie)
CoolSculpting® Elite C150 Applicator
CoolSculpting® Elite Applicator Collection (PRNewsfoto/AbbVie)

“The number one aesthetic concern for consumers is excess body fat1. CoolSculpting® has been an industry-leader, creating the market for non-invasive fat reduction over 10 years ago. Now CoolSculpting® Elite builds on that heritage with a completely re-invented next-generation technology that delivers results,” says Carrie Strom, Senior Vice President, AbbVie, and President, Global Allergan Aesthetics. “We understand the challenges of today’s world and as people prepare to go from being online to spending more time in person, CoolSculpting® Elite can help them address their bothersome fat.” Read Original Article >